Lymecycline

Thông tin thuốc gốc
Chỉ định và Liều dùng
Oral
Acne
Adult: Dose is expressed in terms of lymecycline (408 mg lymecycline is equivalent to 300 mg tetracycline base): 408 mg daily for at least 8 weeks.
Child: ≥12 years Same as adult dose.

Oral
Acute exacerbations of chronic bronchitis, Ear, nose and/or throat infections, Gastrointestinal tract infections, Nongonococcal urethritis, Rickettsial fever, Soft tissue infections, Trachoma, Urinary tract infections
Adult: Dose is expressed in terms of lymecycline (408 mg lymecycline is equivalent to 300 mg tetracycline base): 408 mg bid, may increase to 1,224-1,632 mg over 24 hours, if needed, for severe infections.
Child: ≥12 years Same as adult dose.
Cách dùng
Should be taken on an empty stomach.
Chống chỉ định
Hypersensitivity to lymecycline or other tetracycline antibiotics. Overt renal insufficiency. Children <8 years. Pregnancy and lactation. Concomitant use with oral retinoids.
Thận trọng
Patient with myasthenia gravis or SLE. Hepatic impairment. Children ≥12 years.
Tác dụng không mong muốn
Significant: Oesophageal irritation and ulceration, photosensitivity, benign intracranial hypertension; may exacerbate SLE; fungal or bacterial superinfection including Clostridiodes difficile-associated diarrhoea and pseudomembranous colitis (prolonged use).
Blood and lymphatic system disorders: Neutropenia, thrombocytopenia.
Eye disorders: Visual disturbances.
Gastrointestinal disorders: Nausea, diarrhoea, abdominal pain, vomiting, glossitis, enterocolitis, epigastralgia.
General disorders and administration site conditions: Pyrexia.
Hepatobiliary disorders: Hepatitis, jaundice.
Immune system disorders: Anaphylactic reaction, hypersensitivity reaction, angioneurotic oedema.
Investigations: Increased transaminases, blood alkaline phosphatase, blood bilirubin.
Nervous system disorders: Headache, dizziness.
Psychiatric disorders: Nightmares, depression.
Skin and subcutaneous tissue disorders: Erythematous rash, urticaria, Stevens-Johnson syndrome, pruritus.
Thông tin tư vấn bệnh nhân
Avoid prolonged exposure to direct sunlight and UV light during treatment; use sunblock or protective clothing when going outdoors.
Chỉ số theo dõi
Perform culture and susceptibility tests; consult local institutional recommendations before treatment initiation due to antibiotic resistance risks.
Tương tác
Concomitant use with divalent and trivalent cations (e.g. Mg, Al, Ca, bismuth, and Fe preparations), colestyramine, and quinapril may reduce the absorption of lymecycline. May increase the serum level of lithium. May enhance the effects of anticoagulants, which may increase the risk of haemorrhage. May interfere with the bacteriocidal action of penicillin and β-lactam antibiotics.
Potentially Fatal: Increased risk of benign intracranial hypertension with oral retinoids and vitamin A (>10,000 international units daily). Concomitant use with methoxyflurane may result in renal toxicity.
Ảnh hưởng đến kết quả xét nghiệm
May result in false elevations of urine glucose or urinary catecholamine levels.
Tác dụng
Description:
Mechanism of Action: Lymecycline, a tetracycline derivative, blocks the access of bacterial aminoacyl-transfer RNA to the mRNA-ribosome complex by binding to the 30S ribosomal subunit, thus preventing protein synthesis. Its exact mechanism for the treatment of acne vulgaris has not been fully elucidated; however, its effect is expected to be due to its inhibition of susceptible organisms on the surface of the skin and reduction of free fatty acids in the sebum, which are believed to be a possible cause of inflammatory lesions (e.g. papules, pustules, nodules, cysts) of acne.
Pharmacokinetics:
Absorption: Readily absorbed from the gastrointestinal tract. Time to peak plasma concentration: 3-4 hours.
Distribution: Widely distributed in most body fluids and tissues (notable in the lungs, muscle, bones, liver, prostate, urine, bladder, and bile). Crosses the placenta and enters breast milk.
Excretion: Mainly via urine (25%); bile. Elimination half-life: Approx 10 hours.
Đặc tính

Chemical Structure Image
Lymecycline

Source: National Center for Biotechnology Information. PubChem Compound Summary for CID 54707177, Lymecycline. https://pubchem.ncbi.nlm.nih.gov/compound/Lymecycline. Accessed May 25, 2023.

Bảo quản
Store below 25°C. Protect from light.
Phân loại MIMS
Tetracyclin
Phân loại ATC
J01AA04 - lymecycline ; Belongs to the class of tetracyclines. Used in the systemic treatment of infections.
Tài liệu tham khảo
Anon. Lymecycline. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 11/04/2023.

Buckingham R (ed). Lymecycline. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 11/04/2023.

Joint Formulary Committee. Lymecycline. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 11/04/2023.

Lymecycline 408 mg Capsules, Hard. MHRA. https://products.mhra.gov.uk. Accessed 11/04/2023.

Tetralysal 300 mg Capsule (Galderma Philippines, Inc.). MIMS Philippines. http://www.mims.com/philippines. Accessed 11/04/2023.

Tetralysal 300 mg Hard Capsules (Galderma [U.K.] Limited). MHRA. https://products.mhra.gov.uk. Accessed 11/04/2023.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Lymecycline từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2026 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com